This page includes the latest FDA filings for Impel Neuropharma Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
---|---|---|
Impel Pharmaceuticals Inc. | Prescription Medication | 2023-11-28 |
Impel Pharmaceuticals Inc. | Prescription Medication | 2022-05-18 |
Impel Pharmaceuticals Inc. | Prescription Medication | 2021-09-25 |
Impel NeuroPharma, Inc. | Trudhesa | 2021-09-24 |
IMPEL NEUROPHARMA INC | 2021-09-07 18:52:18 |
NCAGE Code | 55Y39 | IMPEL NEUROPHARMA, INC.!DBA IMPEL BIOPHARMACEUTICALS |
CAGE Code | 55Y39 | IMPEL NEUROPHARMA, INC. IMPEL BIOPHARMACEUTICALS |
SEC | 0001445499 | IMPEL NEUROPHARMA INC of DELAWARE |